Trial Profile
A Retrospective Study Investigating the Effect of Repeated Exposure to Multiple Administrations of the Macrocyclic Gadolinium-Based Contrast Agent (GBCA) Gadoterate Meglumine on Signal Intensity at Unenhanced T1-Weighted Magnetic Resonance in the Globus Pallidus and Dentate Nucleus in a Pediatric Population
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Apr 2018
Price :
$35
*
At a glance
- Drugs Gadoterate-meglumine (Primary)
- Indications CNS disorders; Vascular disorders
- Focus Diagnostic use
- 11 Apr 2018 New trial record